Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Tax withholdingOrdinary Shares | 93 | $89.34 | $8,308.62 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 2 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,578 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
Exercise / conversionOrdinary Shares | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000128 · wk-form4_1754338524.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| July 31, 2025 Filed Aug 1, 2025 17:10 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
Tax withholdingOrdinary Shares | 1,630 | $90.24 | $147,091.20 |
DisclosureSEC source: 0001613103-25-000120 · wk-form4_1754068235.xml · nonDerivative · entry 1 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,743 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:25 UTC |
Pieton ThierryEVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 61,338 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000114 · wk-form4_1753907144.xml · derivative · entry 3 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,338 Underlying: Ordinary Shares · 61,338 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:25 UTC |
Pieton ThierryEVP & Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 21,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000114 · wk-form4_1753907144.xml · derivative · entry 2 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,747 Underlying: Performance Share Unit · 21,747 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,747 shares will be issued. If maximum performance metrics are achieved, 43,494 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:25 UTC |
Pieton ThierryEVP & Chief Financial Officer
|
GrantOrdinary Shares | 8,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000114 · wk-form4_1753907144.xml · nonDerivative · entry 1 Pieton Thierry · CIK 0002056622 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,958 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 505 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:30 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
GrantStock Option (Right to Buy) · Derivative | 30,669 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000118 · wk-form4_1753907401.xml · derivative · entry 3 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,669 Underlying: Ordinary Shares · 30,669 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:30 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
GrantPerformance Share Units · Derivative | 10,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000118 · wk-form4_1753907401.xml · derivative · entry 2 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,874 Underlying: Performance Share Unit · 10,874 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 10,874 shares will be issued. If maximum performance metrics are achieved, 21,748 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:30 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
GrantOrdinary Shares | 4,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000118 · wk-form4_1753907401.xml · nonDerivative · entry 1 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,625 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 99 shares acquired through dividend reinvestment and 122 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:29 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
GrantStock Option (Right to Buy) · Derivative | 69,005 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000117 · wk-form4_1753907342.xml · derivative · entry 3 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,005 Underlying: Ordinary Shares · 69,005 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:29 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
GrantPerformance Share Units · Derivative | 24,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000117 · wk-form4_1753907342.xml · derivative · entry 2 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,465 Underlying: Performance Share Unit · 24,465 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 24,465 shares will be issued. If maximum performance metrics are achieved, 48,930 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:29 UTC |
Wall Brett A.EVP & Pres Neuroscience
|
GrantOrdinary Shares | 9,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000117 · wk-form4_1753907342.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Pres Neuroscience 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,282 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 517 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:28 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
GrantStock Option (Right to Buy) · Derivative | 69,005 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000116 · wk-form4_1753907279.xml · derivative · entry 3 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,005 Underlying: Ordinary Shares · 69,005 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:28 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
GrantPerformance Share Units · Derivative | 24,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000116 · wk-form4_1753907279.xml · derivative · entry 2 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,465 Underlying: Performance Share Unit · 24,465 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 24,465 shares will be issued. If maximum performance metrics are achieved, 48,930 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:28 UTC |
Smith Gregory LEVP Global Ops & Supply Chain
|
GrantOrdinary Shares | 9,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000116 · wk-form4_1753907279.xml · nonDerivative · entry 1 Smith Gregory L · CIK 0001533098 · EVP Global Ops & Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,373 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 1,432 shares acquired through dividend reinvestment and 285 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:24 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
GrantStock Option (Right to Buy) · Derivative | 264,518 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000113 · wk-form4_1753907079.xml · derivative · entry 3 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,518 Underlying: Ordinary Shares · 264,518 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:24 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
GrantPerformance Share Units · Derivative | 93,781 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000113 · wk-form4_1753907079.xml · derivative · entry 2 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,781 Underlying: Performance Share Unit · 93,781 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 93,781 shares will be issued. If maximum performance metrics are achieved, 187,562 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:24 UTC |
Martha GeoffreyDirector · Chairman and CEO
|
GrantOrdinary Shares | 37,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000113 · wk-form4_1753907079.xml · nonDerivative · entry 1 Martha Geoffrey · CIK 0001560409 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,976 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 1,693 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:27 UTC |
Quinn MichelleEVP, GC and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 38,336 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000115 · wk-form4_1753907226.xml · derivative · entry 4 Quinn Michelle · CIK 0001964281 · EVP, GC and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,336 Underlying: Ordinary Shares · 38,336 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:27 UTC |
Quinn MichelleEVP, GC and Secretary
|
GrantPerformance Share Units · Derivative | 13,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000115 · wk-form4_1753907226.xml · derivative · entry 3 Quinn Michelle · CIK 0001964281 · EVP, GC and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,592 Underlying: Performance Share Unit · 13,592 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 13,592 shares will be issued. If maximum performance metrics are achieved, 27,184 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:27 UTC |
Quinn MichelleEVP, GC and Secretary
|
GrantOrdinary Shares | 16,310 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000115 · wk-form4_1753907226.xml · nonDerivative · entry 2 Quinn Michelle · CIK 0001964281 · EVP, GC and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,747 F2 · shares: Represents restricted stock units that vest in three annual installments beginning one year from the date of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:27 UTC |
Quinn MichelleEVP, GC and Secretary
|
GrantOrdinary Shares | 5,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000115 · wk-form4_1753907226.xml · nonDerivative · entry 1 Quinn Michelle · CIK 0001964281 · EVP, GC and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,437 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:23 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
GrantStock Option (Right to Buy) · Derivative | 69,005 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000112 · wk-form4_1753907024.xml · derivative · entry 3 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,005 Underlying: Ordinary Shares · 69,005 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:23 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
GrantPerformance Share Units · Derivative | 24,465 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000112 · wk-form4_1753907024.xml · derivative · entry 2 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,465 Underlying: Performance Share Unit · 24,465 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 24,465 shares will be issued. If maximum performance metrics are achieved, 48,930 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:23 UTC |
Marinaro MichaelEVP, Pres MedSurg and Americas
|
GrantOrdinary Shares | 9,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000112 · wk-form4_1753907024.xml · nonDerivative · entry 1 Marinaro Michael · CIK 0001984186 · EVP, Pres MedSurg and Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,093 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 479 shares acquired through dividend reinvestment and 153 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
GrantStock Option (Right to Buy) · Derivative | 53,671 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000111 · wk-form4_1753906554.xml · derivative · entry 3 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,671 Underlying: Ordinary Shares · 53,671 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
GrantPerformance Share Units · Derivative | 19,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000111 · wk-form4_1753906554.xml · derivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,028 Underlying: Performance Share Unit · 19,028 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 19,028 shares will be issued. If maximum performance metrics are achieved, 38,056 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC |
KIIL HARRY SKIPEVP & President Cardiovascular
|
GrantOrdinary Shares | 7,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000111 · wk-form4_1753906554.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,318 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 264 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 1,278 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000110 · wk-form4_1753906508.xml · derivative · entry 3 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,278 Underlying: Ordinary Shares · 1,278 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
GrantPerformance Share Units · Derivative | 2,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000110 · wk-form4_1753906508.xml · derivative · entry 2 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,202 Underlying: Performance Share Unit · 2,202 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 2,202 shares will be issued. If maximum performance metrics are achieved, 4,404 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC |
Blomquist Denise L.Chief Accounting Officer
|
GrantOrdinary Shares | 2,202 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000110 · wk-form4_1753906508.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,425 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 52 shares acquired through dividend reinvestment and 28 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 20:30 UTC |
Blomquist Denise L.Chief Accounting Officer
|
GiftOrdinary Shares | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000085 · wk-form4_1749069015.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,143 Read SEC document |
| May 02, 2025 Filed May 5, 2025 20:10 UTC |
Walter Matthew R.SVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 34 | $84.85 | $2,884.90 |
DisclosureSEC source: 0001613103-25-000073 · wk-form4_1746475814.xml · nonDerivative · entry 1 Walter Matthew R. · CIK 0002028475 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,054 F1 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 106 shares acquired through dividend reinvestment and 159 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report filed by the reporting person. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:19 UTC |
Lofton Kevin EDirector
|
Tax withholdingOrdinary Shares | 216 | $84.60 | $18,273.60 |
DisclosureSEC source: 0001613103-25-000068 · wk-form4_1746044332.xml · nonDerivative · entry 2 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,171 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:14 UTC |
Fonseca LidiaDirector
|
Tax withholdingOrdinary Shares | 216 | $84.60 | $18,273.60 |
DisclosureSEC source: 0001613103-25-000064 · wk-form4_1746044064.xml · nonDerivative · entry 2 Fonseca Lidia · CIK 0001454944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,675 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:21 UTC |
Powell Kendall JDirector
|
Tax withholdingOrdinary Shares | 216 | $84.60 | $18,273.60 |
DisclosureSEC source: 0001613103-25-000070 · wk-form4_1746044484.xml · nonDerivative · entry 2 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,622 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:12 UTC |
DONNELLY SCOTT CDirector
|
Tax withholdingOrdinary Shares | 216 | $84.60 | $18,273.60 |
DisclosureSEC source: 0001613103-25-000063 · wk-form4_1746043824.xml · nonDerivative · entry 2 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,630 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:17 UTC |
HOGAN RANDALL JDirector
|
Tax withholdingOrdinary Shares | 216 | $84.60 | $18,273.60 |
DisclosureSEC source: 0001613103-25-000066 · wk-form4_1746044202.xml · nonDerivative · entry 2 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,029 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:11 UTC |
ARNOLD CRAIGDirector
|
Tax withholdingOrdinary Shares | 216 | $84.60 | $18,273.60 |
DisclosureSEC source: 0001613103-25-000062 · wk-form4_1746043712.xml · nonDerivative · entry 2 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,216 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:20 UTC |
NABEL ELIZABETH GDirector
|
Tax withholdingOrdinary Shares | 216 | $84.60 | $18,273.60 |
DisclosureSEC source: 0001613103-25-000069 · wk-form4_1746044411.xml · nonDerivative · entry 2 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,615 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:18 UTC |
Lewis Gregory PDirector
|
Tax withholdingOrdinary Shares | 181 | $84.60 | $15,312.60 |
DisclosureSEC source: 0001613103-25-000067 · wk-form4_1746044271.xml · nonDerivative · entry 2 Lewis Gregory P · CIK 0001748656 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,785 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 29, 2025 Filed Apr 30, 2025 20:15 UTC |
Goldsmith Andrea JoDirector
|
Tax withholdingOrdinary Shares | 216 | $84.60 | $18,273.60 |
DisclosureSEC source: 0001613103-25-000065 · wk-form4_1746044143.xml · nonDerivative · entry 2 Goldsmith Andrea Jo · CIK 0001730514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,247 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:19 UTC |
Lofton Kevin EDirector
|
GrantOrdinary Shares | 2,083 | $84.04 | $175,055.32 |
DisclosureSEC source: 0001613103-25-000068 · wk-form4_1746044332.xml · nonDerivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,387 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 74 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:14 UTC |
Fonseca LidiaDirector
|
GrantOrdinary Shares | 2,083 | $84.04 | $175,055.32 |
DisclosureSEC source: 0001613103-25-000064 · wk-form4_1746044064.xml · nonDerivative · entry 1 Fonseca Lidia · CIK 0001454944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,891 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 126 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:21 UTC |
Powell Kendall JDirector
|
GrantOrdinary Shares | 2,083 | $84.04 | $175,055.32 |
DisclosureSEC source: 0001613103-25-000070 · wk-form4_1746044484.xml · nonDerivative · entry 1 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,838 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 912 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:12 UTC |
DONNELLY SCOTT CDirector
|
GrantOrdinary Shares | 2,083 | $84.04 | $175,055.32 |
DisclosureSEC source: 0001613103-25-000063 · wk-form4_1746043824.xml · nonDerivative · entry 1 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,846 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 159 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:17 UTC |
HOGAN RANDALL JDirector
|
GrantOrdinary Shares | 2,083 | $84.04 | $175,055.32 |
DisclosureSEC source: 0001613103-25-000066 · wk-form4_1746044202.xml · nonDerivative · entry 1 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,245 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 74 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:11 UTC |
ARNOLD CRAIGDirector
|
GrantOrdinary Shares | 2,083 | $84.04 | $175,055.32 |
DisclosureSEC source: 0001613103-25-000062 · wk-form4_1746043712.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,432 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 74 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:20 UTC |
NABEL ELIZABETH GDirector
|
GrantOrdinary Shares | 2,083 | $84.04 | $175,055.32 |
DisclosureSEC source: 0001613103-25-000069 · wk-form4_1746044411.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,831 F1 · shares: Represents an award of restricted stock units that vest on the one-year anniversary of the award date. F2 · balance_after: Includes 74 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 20:22 UTC |
Blomquist Denise L.Chief Accounting Officer
|
GrantOrdinary Shares | 2,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000071 · wk-form4_1746044537.xml · nonDerivative · entry 1 Blomquist Denise L. · CIK 0002061393 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,453 F1 · shares: Represents restricted stock units that vest in three annual installments beginning one year from the date of grant. F2 · balance_after: Includes 62 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.